enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.750
+0.040 (2.34%)
At close: Jun 24, 2026, 4:00 PM EDT
1.740
-0.010 (-0.57%)
After-hours: Jun 24, 2026, 7:06 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $117.23 million as of June 24, 2026. Its market cap has decreased by -31.48% in one year.
Market Cap
117.23M
Enterprise Value
-106.88M
1-Year Change
-31.48%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $117.23M, a decrease of -24.81%. That is a compound annual growth rate of -6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 117.23M | -80.62% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genelux | 126.79M |
| Coya Therapeutics | 124.79M |
| Fractyl Health | 122.95M |
| PepGen | 122.43M |
| Agenus | 121.60M |
| Spero Therapeutics | 121.59M |
| NeOnc Technologies Holdings | 120.25M |
| Aldeyra Therapeutics | 114.61M |